Sophie Badie
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.
Journal: EMBO molecular medicine
Published: October 26, 2018
Corrigendum: MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells.
Journal: Nature communications
Published: October 27, 2017
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
Journal: EMBO molecular medicine
Published: July 22, 2017
MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells.
Journal: Nature communications
Published: November 24, 2016
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds.
Journal: Molecular cell
Published: March 27, 2015
BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres.
Journal: The EMBO journal
Published: March 14, 2015
BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres.
Journal: The EMBO journal
Published: January 14, 2015
ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets.
Journal: Nature communications
Published: August 27, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026